非酒精性脂肪性肝病的肝靶向治疗研究进展
Nonalcoholic fatty liver disease (NAFLD) is the most common progressive liver disease worldwide. Currently, there is no satisfying treatment for NAFLD. Research progress in fatty acid bile acid conjugates (FABACs) and ursodeoxycholyl lysophosphatidylethanolamide (UDCA-LPE), which are two novel liver...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Hepatology
2014-05-01
|
| Series: | Linchuang Gandanbing Zazhi |
| Subjects: | |
| Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=5864&ClassID=4241471 |